Skip to main content
NIPH logo

All about antimicrobial resistance

22 hits
  1. NORM and NORM-VET: Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway

    NORM and NORM-VET: Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway

    Updated

    This report from NORM and NORM-VET presents data of occurrence of antimicrobial resistance and usage of antimicrobial agents in Norway in humans and animals in 2023.
    Report
    NORM forside rapport 2023
  2. EU interoperability with HERA's IT platform (EU-HIP)

    EU interoperability with HERA's IT platform (EU-HIP)

    Updated

    The objective of EU-HIP is to support the participating countries in improving their national IT systems, with the aim of sufficient interoperability with HERA's (Health and Emergency Response Authority) IT platform.
    Project
  3. NORM og NORM-VET: Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway

    NORM og NORM-VET: Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway

    Updated

    This report from NORM and NORM-VET presents data of occurrence  of antimicrobial resistance and usage of antimicrobial agents in Norway in humans and animals in 2022.
    Report
    forside NORM
  4. Triclosan coated sutures for prevention of surgical site infection - Protocol for health technology assessment

    Triclosan coated sutures for prevention of surgical site infection - Protocol for health technology assessment

    Updated

    The Norwegian Institute of Public Health has been asked to investigate effectiveness, safety, and health economic consequences of using absorbable triclosan coated sutures compared to standard absorbable sutures, without triclosan, to prevent surgical site infection.
    Project
  5. The largest ever One Health project funded by the EU's Horizon 2020

    The largest ever One Health project funded by the EU's Horizon 2020

    Updated

    The Norwegian Institute of Public Health actively participates in 60 EU projects, where the One Health European Joint Programme is one of the largest with 42 partners.
    Article
    One health bilde.jpg
  6. Antibiotic use during pregnancy linked to childhood asthma

    Antibiotic use during pregnancy linked to childhood asthma

    Updated

    Both maternal antibiotic use and infections during pregnancy are associated with childhood asthma at 7 years, according to a new MoBa study.
    Research findings
    Illustrasjonsfoto
  7. NORM og NORM-VET: Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway

    NORM og NORM-VET: Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway

    Updated

    This report, which is the twenty-first annual joint report from NORM and NORM-VET, presents data on resistance and usage for 2021.
    Report
    Norm Norm-vet_Rapport_Side_001.png
  8. Antibiotic resistance

    Antibiotic resistance

    Updated

    This information from WHO has been translated to Ukrainian and has been used on the website of the Ministry of Health in Ukraine.
    Poster
    Engelsk-English_What is antibiotic resistance and what you can do.jpg
  9. Viruses monitored for resistance

    Viruses monitored for resistance

    Updated

    In Norwegian Surveillance System for Antiviral Resistance (RAVN), resistance of influenza viruses, HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), cytomegalovirus (CMV) and herpes simplex virus (HSV) are monitored.
    Article
    logo som viser to ravner
  10. NORM and NORM-VET: Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway

    NORM and NORM-VET: Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway

    Updated

    This report, which is the twenty-first annual joint report from NORM and NORM-VET, presents data on resistance and usage for 2020.
    Report
    NORM og NORM-VET Usage of Antimicrobial  Agents and Occurrence of Antimicrobial Resistance  in Norway
  11. One Health

    One Health

    Updated

    'One Health' is an approach for designing and implementing programmes, policies, legislation and research where multiple sectors communicate and work together to achieve better public health outcomes.
    Article
    Illustration of One Health
  12. Empiric treatment with antibiotic combination therapy compared with monotherapy for adult patients with septic shock of unknown pathogen and origin

    Empiric treatment with antibiotic combination therapy compared with monotherapy for adult patients with septic shock of unknown pathogen and origin

    Updated

    We were asked to conduct a systematic review of effect and safety of empiric treatment with antibiotic combination therapy compared with monotherapy for adult patients with septic shock.
    Systematic review
    Forside_Septic Shock.jpg
  13. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2018

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2018

    Updated

    The annual report from Resistance against antivirals in Norway (RAVN) with national data about antiviral resistance, focusing on relevant topics related to treatment of viral infections.
    Report
    RAVN 2019 omslag_web.jpg
  14. Development Plan for Global Health

    Development Plan for Global Health

    Updated

    This development plan for global health has a long-term, strategic perspective.
    Brochure
    Cover picture of publication
  15. Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective

    Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective

    Updated

    The aim of this study was to explore all Brucella melitensis isolates collected in Norway from 1999 to 2016 in relation to origin of infection and antimicrobial resistance patterns.
    Project
  16. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2017

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2017

    Updated

    The annual report from Resistance against Antivirals in Norway (RAVN) presents national surveillance data on antiviral resistance for a number of viruses.
    Report
    Ravn 2017_Omslag.jpg
  17. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2016

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2016

    Updated

    The annual report from Resistance against Antivirals in Norway (RAVN) presents national surveillance data on antiviral resistance and focuses on topics related to treatment of viral infections.
    Report
    RAVN-rapport 2016_Forside_web.jpg
  18. Effect of using aminoglycosides for treatment of sepsis

    Effect of using aminoglycosides for treatment of sepsis

    Updated

    Systematically review of the evidence on the treatment effects and harms of any antibiotic regimen with an aminoglycoside versus any antibiotic regimen without an aminoglycoside for sepsis in adults.
    Systematic review
  19. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2015

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2015

    Updated

    This is the third report from Resistance against Antivirals in Norway (RAVN). The report includes antiviral medicine use and surveillance data about viral resistance for 2015.
    Report
    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2015 - RAVN.jpg
  20. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2011-2012

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2011-2012

    Updated

    The 2011-2012 report includes general information about the RAVN surveillance system as well as virus resistance in Norway during the period.
    Report
  21. About the Norwegian Surveillance System for Antimicrobial Drug Resistance (NORM)

    About the Norwegian Surveillance System for Antimicrobial Drug Resistance (NORM)

    Updated

    The Norwegian Surveillance System for Antimicrobial Drug Resistance (NORM) is a national health registry that was established in 2000.
    Article
    Illustrasjonsfoto av bakterier
  22. Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2013-2014

    Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2013-2014

    Updated

    This is the second report from Resistance against Antivirals in Norway (RAVN) about the usage of antiviral medicines and surveillance data for viral resistance for the biannual period 2013–2014.
    Report
    Usage og Antivirals.jpg